Printer Friendly
The Free Library
4,482,222 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Agilent Technologies and Midwest Research Institute Announce Project in Homeland Security, Biodefense.


PALO ALTO, Calif. & KANSAS CITY, Mo. -- Agilent Technologies Inc. (NYSE:A) and Midwest Research Institute (MRI), a leading center for biological and chemical defense research in the United States, today announced a project to evaluate instrumentation for use in the areas of homeland security and biodefense.

Agilent provided MRI with the Agilent 2100 bioanalyzer and Agilent 5100 automated lab on a chip A semiconductor chip used to analyze the composition of a person's body fluids (blood, saliva, urine) for medical purposes. It combines microfluidics and semiconductor processing on the same chip. See microfluidics and nanotechnology. in order to evaluate the capability of the analytical instruments in high-throughput pathogen detection. In return, MRI provided feedback on the performance of these instruments in biodefense applications.

As part of this project, MRI's scientists and engineers have worked with Agilent's product development team to evaluate the performance of the Agilent 5100, testing it in field conditions where it was subjected to a level of real-world demand not available in Agilent's development labs.

"Based on our evaluation, we've concluded that the Agilent 5100 automated LOC platform is a promising instrument for automated high-throughput sample screening in biodefense applications," said Steve Lufkin, MRI's senior vice president of technology and strategic business development.

MRI put the instrument through the rigorous paces of its high-throughput monitoring of biological-threat agents using its multiplexing Transmitting multiple signals over a single communications line or computer channel. The two common multiplexing techniques are FDM, which separates signals by modulating the data onto different carrier frequencies, and TDM, which separates signals by interleaving bits one after the other. PCR (polymerase chain reaction). Multiplexing PCR provides for the detection of multiple DNA signatures associated with a single agent or multiple agents. During the evaluation, nearly 1,500 PCR assays were run using about 500 environmental samples.

"Multiplexing PCR is definitely on the radar screen of the industry involved in biodefense analysis work," said Lufkin. "Within the biodefense environment, there is an urgent need to balance accuracy with the cost and speed of collecting and analyzing volumes of critical information. It is essential to have bioanalysis equipment, such as the Agilent 5100, that makes full use of our multiplexing capabilities."

About Midwest Research Institute

Midwest Research Institute (MRI) is an independent, not-for-profit laboratory that has conducted scientific research for government and industry since 1944. Its programs span the areas of national security and defense, life sciences, energy, engineering, and agriculture and food safety. MRI has managed and operated the National Renewable Energy Laboratory for the U.S. Department of Energy since 1977. Headquartered in Kansas City, Mo., MRI has additional laboratories in Florida and Maryland. More information is available at www.mriresearch.org.

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is a global technology leader in communications, electronics, life sciences and chemical analysis chemical analysis, the study of the chemical composition and structure of substances. More broadly, it may be considered the corpus of all techniques whereby any exact chemical information is obtained. There are two branches in analytical chemistry: qualitative analysis and quantitative analysis. Qualitative analysis is the determination of those elements and compounds that are present in a sample of unknown material.. Agilent had net revenue of $7.2 billion in fiscal year 2004. Information about Agilent is available on the Web at www.agilent.com.

NOTE TO EDITORS: Press releases, photography and other information can be accessed on the Agilent Life Sciences and Chemical Analysis newsroom at www.agilent.com/about/newsroom/lsca.

Further technology, corporate citizenship and executive news is available on the Agilent news site at www.agilent.com/go/news.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 2, 2005
Words:467
Previous Article:GlobalSpec Claims Spotlight as Leader in B2B Vertical Search and Lead Generation; Sales Growth of 65%; Registered Users Up 86% to 1.7MM.
Next Article:DKRW Energy Plans to Develop a $2.75 Billion Coal Liquefaction Plant and Cogen in the Rocky Mountains, an Advisory from Industrialinfo.com.



Related Articles
R&D for Defense, NASA garner funding rise. (Budget Boosts and Busts).(federal budget)
Plans for protection against agricultural terrorism.(EH Update)
IGEN supplies botulinum toxin tests to USDA's Food Safety and Inspection Service.(Products & Services)
Simulated agent mimics bio-terror weapons.(Security beat: homeland defense briefs)(Brief Article)
U.S. BIODEFENSE/UCL BIOMEDICA GET OPTION TO LICENSE PATENT.
The George Washington University Homeland Security Policy Institute.(People & Politics)(Brief Article)
PathAlert Infectious-Agent Detection System.(Products & Services)
Biodefense experts: vaccines 'at a crossroads'.(GERM WARFARE)
Biodefense: research methodology and animal models.
Plague proteome reveals proteins linked to infection.(EH Update)

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles